<SEC-DOCUMENT>0001628280-23-041614-index.html : 20231214
<SEC-HEADER>0001628280-23-041614.hdr.sgml : 20231214
<ACCEPTANCE-DATETIME>20231214170947
ACCESSION NUMBER:		0001628280-23-041614
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20231214
DATE AS OF CHANGE:		20231214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276052
		FILM NUMBER:		231487894

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>a2023decembers-3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: a2023decembers-3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>a2023decs-3feeexhibit107.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 2 - file: a2023decs-3feeexhibit107.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>a2023decs-3atmexhibit5.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: a2023decs-3atmexhibit5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>a2023decs-3auditorconsente.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 4 - file: a2023decs-3auditorconsente.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: image_0a.jpg

</DOCUMENT>
</SEC-DOCUMENT>